Updated:
Lpath
Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular...
Lpath
Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Miami
Corporate office
Miami, Florida, United States
Additional offices
Alexandria, Virginia, United States · Pasadena, California, United States · Austin, Texas, United States · Bethesda, Maryland, United States · San Diego, California, United States
Frequently asked questions
Who runs investment decisions at Lpath?
No principals or investment committee members have been publicly named for Lpath. The firm does not maintain a public website or LinkedIn presence that lists leadership. Without voluntary disclosure, the decision-making structure is unknown.
Is Lpath structured as a single family office or a multi-family office?
Public records do not specify Lpath's legal or operational structure. The firm's six-city office footprint could support either a single-family office with distributed operations or a multi-family office serving multiple families. No confirmatory evidence is publicly available.
What investment strategy does Lpath follow?
Lpath has not publicly disclosed its investment strategy, asset-class preferences, or geographic focus. The firm's multiple US offices — in Miami, Alexandria, Pasadena, Austin, Bethesda, and San Diego — suggest national reach, but no sector tags, stage targets, or portfolio companies have been identified in public sources.
Does Lpath participate in fund commitments or only direct deals?
No public information exists about Lpath's investment vehicle preferences — whether it commits to external funds, executes direct deals, or uses a hybrid approach. The firm's deal structure remains opaque.
Where does the underlying wealth for Lpath come from?
The origin of capital managed or deployed by Lpath has not been disclosed. Without named principals or a wealth-origin statement, the underlying capital source is unknown.
How many professionals work at Lpath?
Lpath has not publicly disclosed its team size or professional headcount. The firm's six-office network implies a team of at least several individuals, but no precise number is available.
Does Lpath maintain philanthropic structures?
No philanthropic entities, foundations, or charitable arms have been publicly linked to Lpath. The firm's non-profit activities, if any, are not documented in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: